Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

4.56USD
10:05am EST
Change (% chg)

$-0.04 (-0.87%)
Prev Close
$4.60
Open
$4.57
Day's High
$4.60
Day's Low
$4.53
Volume
30,241
Avg. Vol
429,966
52-wk High
$9.41
52-wk Low
$4.24

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.11 December 17 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 3
(2) OUTPERFORM 2 2 2 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 4 10.69 17.94 4.80 23.20
Quarter Ending Mar-19 1 13.30 13.30 13.30 --
Year Ending Dec-18 4 23.08 30.33 17.30 41.52
Year Ending Dec-19 4 66.82 82.20 42.40 88.87
Earnings (per share)
Quarter Ending Dec-18 4 -0.11 -0.02 -0.17 0.01
Quarter Ending Mar-19 1 -0.07 -0.07 -0.07 --
Year Ending Dec-18 4 -0.80 -0.71 -0.86 -0.62
Year Ending Dec-19 4 -0.23 -0.07 -0.39 -0.12

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 4.12 5.32 1.20 29.03
Quarter Ending Jun-18 3.67 3.88 0.21 5.74
Quarter Ending Mar-18 4.35 3.19 1.16 26.69
Quarter Ending Dec-17 3.20 3.89 0.69 21.53
Quarter Ending Sep-17 3.52 2.70 0.82 23.38

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 10.69 10.69 10.03 10.03 23.20
Quarter Ending Mar-19 13.30 13.30 13.30 13.30 --
Year Ending Dec-18 23.08 23.08 21.30 21.30 41.52
Year Ending Dec-19 66.82 66.82 71.23 71.23 88.87

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 3 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 4 0
Year Ending Dec-19 0 0 1 2
Earnings